{
  "main_header": {
    "sid": 179255,
    "name": "Vimta Labs",
    "stock_name": "Vimta Labs",
    "full_name": "Vimta Labs Ltd",
    "name_url": "stocks-analysis/vimta-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "602.35",
    "chg": -6.25,
    "chgp": "-1.03%",
    "dir": -1,
    "prev_price": "608.60",
    "mcapval": "2,688.60 Cr",
    "mcap": "Small Cap",
    "scripcode": 524394,
    "symbol": "VIMTALABS",
    "ind_name": "Healthcare Services",
    "ind_code": 26,
    "indexname": "",
    "isin": "INE579C01029",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "43.16 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vimta-labs-179255-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Vimta Labs Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marketsmojo-downgrades-vimta-labs-from-buy-to-hold-amid-valuation-concerns-3736933",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VimtaLabs_mojoScore_3736933.png",
        "date": "2025-11-29 17:52:00",
        "description": "Vimta Labs, a player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of strong operational performance but tempered by valuation concerns and recent changes in promoter shareholding."
      },
      {
        "title": "Why is Vimta Labs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vimta-labs-fallingrising-3719184",
        "imagepath": "",
        "date": "2025-11-21 00:25:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>Vimta Labs’ recent price action reflects a modest pullback, with the stock underperforming its sector by 0.38% on the day. Over the past week and month, the stock has declined by 3.44% and 9.70% respectively, contrasting with the Sensex’s positive returns of 1.37% and 1.50% over the same periods. This divergence suggests that short-term market sentiment has weighed on Vimta Labs, possibly due to profit-taking or technical factors.</p>\n<p>Notably, the stock remains above its 200-day moving average, signalling a strong long-term trend. However, it is trading below its 5-day, 20-day, 50-day, and 100-day moving averages, indicating recent downward momentum. Investor participation has slightly increased, with delivery volumes on 19 Nov ..."
      },
      {
        "title": "Why is Vimta Labs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vimta-labs-fallingrising-3680843",
        "imagepath": "",
        "date": "2025-11-07 22:26:16",
        "description": "As of 07-Nov, Vimta Labs Ltd is experiencing a price increase, currently at 655.95, reflecting a rise of 34.0 or 5.47%. Today's performance indicates a trend reversal as the stock has gained after three consecutive days of decline. It outperformed its sector by 4.93%, reaching an intraday high of Rs 668.35. Despite a negative return of 9.56% over the past week, the stock has shown impressive long-term performance, with a 127.54% increase over the past year, significantly outpacing the market's 4.62% return. The company has also demonstrated strong financial health, with a low debt-to-equity ratio and consistent positive results over the last four quarters, contributing to investor confidence.\n\nBroader Market Context: In the short term, Vimta Labs' performance has been notably weaker than the benchmark, with a 1-month decline of 12.31% compared to the Sensex's gain of 1.57%. However, the stock's year-to-date..."
      },
      {
        "title": "Why is Vimta Labs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vimta-labs-fallingrising-3676756",
        "imagepath": "",
        "date": "2025-11-06 22:07:47",
        "description": "As of 06-Nov, Vimta Labs Ltd is experiencing a decline in its stock price, currently at Rs 621.95, which reflects a decrease of Rs 39.4 or 5.96%. The stock has underperformed its sector by 2.78% today and has been on a consecutive downward trend for the last three days, resulting in a total drop of 14.24% during this period. Despite this recent decline, the stock has shown impressive long-term growth, with a 113.36% increase over the past year, significantly outperforming the market benchmark. The company has reported strong financials, including a low debt-to-equity ratio and consistent positive operating results, which contribute to its overall healthy long-term growth outlook.\n\nIn the broader market context, Vimta Labs' short-term performance has been notably weaker than the benchmark, with a 1-week return of -13.11% compared to the Sensex's -1.30%. This underperformance is compounded by a sector-wide de..."
      },
      {
        "title": "How has been the historical performance of Vimta Labs?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-vimta-labs-3668030",
        "imagepath": "",
        "date": "2025-11-03 22:48:09",
        "description": "Answer:\nThe historical performance of Vimta Labs shows a mixed trend in its financial metrics over the past five years.\n\nBreakdown:\nVimta Labs reported net sales of 288.60 Cr in March 2024, a decrease from 318.19 Cr in March 2023, but an increase from 278.28 Cr in March 2022. The total operating income followed a similar pattern, with 288.60 Cr in March 2024 compared to 318.19 Cr in the previous year. The total expenditure, excluding depreciation, decreased to 194.56 Cr in March 2024 from 223.28 Cr in March 2023. Operating profit (PBDIT) slightly declined to 97.75 Cr in March 2024 from 98.35 Cr in March 2023, while profit before tax decreased to 62.50 Cr from 65.00 Cr in the same period. However, profit after tax increased to 48.81 Cr in March 2024 from 48.17 Cr in March 2023. The earnings per share (EPS) fell to 18.51 in March 2024 from 21.75 in March 2023, reflecting a decrease in profitability per share...."
      },
      {
        "title": "Are Vimta Labs latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-vimta-labs-latest-results-good-or-bad-3667519",
        "imagepath": "",
        "date": "2025-11-03 19:14:22",
        "description": "Vimta Labs has reported its financial results for Q2 FY26, showcasing significant operational performance. The company achieved a net profit of ₹15.25 crores, reflecting a year-on-year growth of 140.92%. Revenue for the quarter reached ₹84.74 crores, marking a year-on-year increase of 29.30% and a sequential improvement of 13.17% from the previous quarter. This growth indicates a strengthening demand across its diversified service offerings in the pharmaceutical, biopharmaceutical, food, consumer goods, and healthcare sectors.\n\nThe operating margin for the quarter stood at 35.28%, which is an improvement of 872 basis points compared to the same quarter last year, highlighting the company's ability to enhance operational efficiencies. Additionally, Vimta Labs reported a return on equity of 17.82%, indicating effective capital utilization.\n\nDespite these strong results, the market reacted by taking profits, l..."
      },
      {
        "title": "Vimta Labs Q2 FY26: Stellar 141% Profit Surge Masks Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/vimta-labs-q2-fy26-stellar-141-profit-surge-masks-valuation-concerns-3666948",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VimtaLabs_quaterlyResult_3666948.png",
        "date": "2025-11-03 16:16:26",
        "description": "Vimta Labs Ltd., India's comprehensive contract research and testing organisation, delivered a blockbuster second quarter for fiscal year 2026, with consolidated net profit surging 140.92% year-on-year to ₹15.25 crores, up from ₹6.33 crores in Q2 FY25. The Hyderabad-based healthcare services provider, commanding a market capitalisation of ₹3,166 crores, demonstrated robust operational momentum with revenue climbing 29.30% YoY to ₹84.74 crores, marking one of its strongest quarterly performances in recent years."
      },
      {
        "title": "When is the next results date for Vimta Labs?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-vimta-labs-3656930",
        "imagepath": "",
        "date": "2025-10-29 23:17:30",
        "description": "Vimta Labs will declare its results on 03 November 2025...."
      },
      {
        "title": "Why is Vimta Labs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vimta-labs-fallingrising-3623730",
        "imagepath": "",
        "date": "2025-10-15 22:05:59",
        "description": "As of 15-Oct, Vimta Labs Ltd's stock price is currently at Rs 699.00, reflecting an increase of Rs 11.0 or 1.6%. Today's price summary indicates that the stock outperformed its sector by 2.37%, reaching an intraday high of Rs 708.2, which is a 2.94% increase. Despite a negative return of -11.57% over the past month, the stock has shown impressive long-term performance, with a year-to-date increase of 40.50% and a remarkable 154.64% rise over the past year. The company has demonstrated strong financial health, with a low debt-to-equity ratio of 0.03 times and consistent positive results over the last three quarters, including record operating cash flow and net sales.\n\nBroader Market Context: In the context of the broader market, Vimta Labs' recent performance contrasts with the Sensex, which has gained 1.00% over the past month. While the stock has struggled in the short term, its long-term growth trajectory..."
      }
    ],
    "total": 5752,
    "sid": "179255",
    "stock_news_url": "https://www.marketsmojo.com/news/vimta-labs-179255"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "24-Nov-2025",
      "details": "Schedule of Analyst/ Institutional Investors Meet",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements",
      "datetime": "21-Nov-2025",
      "details": "Intimation of Shares Transferred by Andhra Pradesh Industrial Development Corporation Limited to Telangana State Industrial Development Corporation Limited",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "17-Nov-2025",
      "details": "ESOP Allotment - The ESOP Allotment Committee of the Board of Directors at their meeting held today i.e. 17th November 2025 has allotted Equity shares to the eligible employee as per Vimta Labs Employee Stock Option Plan 2021.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Vimta Labs Ltd has declared <strong>100%</strong> dividend, ex-date: 30 May 25",
          "dt": "2025-05-30",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Vimta Labs Ltd has announced <strong>2:10</strong> stock split, ex-date: 24 Feb 06",
          "dt": "2006-02-24",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Vimta Labs Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 13 Jun 25",
          "dt": "2025-06-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vimta Labs Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-11-29 17:52:00

Vimta Labs, a player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of strong operational performance but tempered by valuation concerns and recent changes in promoter shareholding.

Read More

Why is Vimta Labs falling/rising?

2025-11-21 00:25:02

Short-Term Price Movement and Market Context

Vimta Labs’ recent price action reflects a modest pullback, with the stock underperforming its sector by 0.38% on the day. Over the past week and month, the stock has declined by 3.44% and 9.70% respectively, contrasting with the Sensex’s positive returns of 1.37% and 1.50% over the same periods. This divergence suggests that short-term market sentiment has weighed on Vimta Labs, possibly due to profit-taking or technical factors.

Notably, the stock remains above its 200-day moving average, signalling a strong long-term trend. However, it is trading below its 5-day, 20-day, 50-day, and 100-day moving averages, indicating recent downward momentum. Investor participation has slightly increased, with delivery volumes on 19 Nov ...

Read More

Why is Vimta Labs falling/rising?

2025-11-07 22:26:16

As of 07-Nov, Vimta Labs Ltd is experiencing a price increase, currently at 655.95, reflecting a rise of 34.0 or 5.47%. Today's performance indicates a trend reversal as the stock has gained after three consecutive days of decline. It outperformed its sector by 4.93%, reaching an intraday high of Rs 668.35. Despite a negative return of 9.56% over the past week, the stock has shown impressive long-term performance, with a 127.54% increase over the past year, significantly outpacing the market's 4.62% return. The company has also demonstrated strong financial health, with a low debt-to-equity ratio and consistent positive results over the last four quarters, contributing to investor confidence. Broader Market Context: In the short term, Vimta Labs' performance has been notably weaker than the benchmark, with a 1-month decline of 12.31% compared to the Sensex's gain of 1.57%. However, the stock's year-to-date...

Read More

Why is Vimta Labs falling/rising?

2025-11-06 22:07:47

As of 06-Nov, Vimta Labs Ltd is experiencing a decline in its stock price, currently at Rs 621.95, which reflects a decrease of Rs 39.4 or 5.96%. The stock has underperformed its sector by 2.78% today and has been on a consecutive downward trend for the last three days, resulting in a total drop of 14.24% during this period. Despite this recent decline, the stock has shown impressive long-term growth, with a 113.36% increase over the past year, significantly outperforming the market benchmark. The company has reported strong financials, including a low debt-to-equity ratio and consistent positive operating results, which contribute to its overall healthy long-term growth outlook. In the broader market context, Vimta Labs' short-term performance has been notably weaker than the benchmark, with a 1-week return of -13.11% compared to the Sensex's -1.30%. This underperformance is compounded by a sector-wide de...

Read More

How has been the historical performance of Vimta Labs?

2025-11-03 22:48:09

Answer: The historical performance of Vimta Labs shows a mixed trend in its financial metrics over the past five years. Breakdown: Vimta Labs reported net sales of 288.60 Cr in March 2024, a decrease from 318.19 Cr in March 2023, but an increase from 278.28 Cr in March 2022. The total operating income followed a similar pattern, with 288.60 Cr in March 2024 compared to 318.19 Cr in the previous year. The total expenditure, excluding depreciation, decreased to 194.56 Cr in March 2024 from 223.28 Cr in March 2023. Operating profit (PBDIT) slightly declined to 97.75 Cr in March 2024 from 98.35 Cr in March 2023, while profit before tax decreased to 62.50 Cr from 65.00 Cr in the same period. However, profit after tax increased to 48.81 Cr in March 2024 from 48.17 Cr in March 2023. The earnings per share (EPS) fell to 18.51 in March 2024 from 21.75 in March 2023, reflecting a decrease in profitability per share....

Read More

Are Vimta Labs latest results good or bad?

2025-11-03 19:14:22

Vimta Labs has reported its financial results for Q2 FY26, showcasing significant operational performance. The company achieved a net profit of ₹15.25 crores, reflecting a year-on-year growth of 140.92%. Revenue for the quarter reached ₹84.74 crores, marking a year-on-year increase of 29.30% and a sequential improvement of 13.17% from the previous quarter. This growth indicates a strengthening demand across its diversified service offerings in the pharmaceutical, biopharmaceutical, food, consumer goods, and healthcare sectors. The operating margin for the quarter stood at 35.28%, which is an improvement of 872 basis points compared to the same quarter last year, highlighting the company's ability to enhance operational efficiencies. Additionally, Vimta Labs reported a return on equity of 17.82%, indicating effective capital utilization. Despite these strong results, the market reacted by taking profits, l...

Read More

Vimta Labs Q2 FY26: Stellar 141% Profit Surge Masks Valuation Concerns

2025-11-03 16:16:26

Vimta Labs Ltd., India's comprehensive contract research and testing organisation, delivered a blockbuster second quarter for fiscal year 2026, with consolidated net profit surging 140.92% year-on-year to ₹15.25 crores, up from ₹6.33 crores in Q2 FY25. The Hyderabad-based healthcare services provider, commanding a market capitalisation of ₹3,166 crores, demonstrated robust operational momentum with revenue climbing 29.30% YoY to ₹84.74 crores, marking one of its strongest quarterly performances in recent years.

Read More

When is the next results date for Vimta Labs?

2025-10-29 23:17:30

Vimta Labs will declare its results on 03 November 2025....

Read More

Why is Vimta Labs falling/rising?

2025-10-15 22:05:59

As of 15-Oct, Vimta Labs Ltd's stock price is currently at Rs 699.00, reflecting an increase of Rs 11.0 or 1.6%. Today's price summary indicates that the stock outperformed its sector by 2.37%, reaching an intraday high of Rs 708.2, which is a 2.94% increase. Despite a negative return of -11.57% over the past month, the stock has shown impressive long-term performance, with a year-to-date increase of 40.50% and a remarkable 154.64% rise over the past year. The company has demonstrated strong financial health, with a low debt-to-equity ratio of 0.03 times and consistent positive results over the last three quarters, including record operating cash flow and net sales. Broader Market Context: In the context of the broader market, Vimta Labs' recent performance contrasts with the Sensex, which has gained 1.00% over the past month. While the stock has struggled in the short term, its long-term growth trajectory...

Read More

View All News